Moderator: Peter Slavin, MD, President, MGH
Terri Bresenham, Chief Innovation Officer, GE Healthcare
Frans van Houten, CEO, Philips
Jeffrey Leiden, MD, PhD, CEO, Vertex
Bernd Montag, PhD, CEO, Siemens Healthineers
Chief executives share perspectives on the impact of AI on their respective companies and industry segments. How prominently does AI figure into current investment strategies? And how are they measuring return on existing investments in AI? Panelists will be asked to take a position on whether AI is a truly transformational technology.
